HSN-003

N/A

Report date: 2025/09/23 09:11:27
NME

Base Information

Drug NameHSN-003
Drug Alias NameHSN-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 21 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 21
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChongqing Pharscin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Pharscin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A